secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001438133-25-000112
Event type: litigation
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tandem settles patent disputes with Roche, agrees to pay $36M over five years
-----------------------------------------------------------------------------

- Settlement resolves pending patent actions in France and Germany regarding t:slim X2 pump and two EP patents.
- Total consideration $36M; initial $8M payment due, remainder in four equal annual installments.
- Parties exchange non-exclusive, non-royalty-bearing cross-licenses to insulin delivery system patents for 10 years.
- Tandem and Roche mutually release claims and covenant not to sue related to the disputed patents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813325000112/0001438133-25-000112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813325000112/tndm-20250521.htm
  HTML page:      https://secwatch.observer/filing/0001438133-25-000112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer